Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN) -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (185)	6/19/1999 6:47:00 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 233

Perhaps Trovan trouble will attract some interest to Magainin, although not likely until after FDA approval, if/when that comes. I should think the sort of person who holds Pfizer is not the same as the sort of investor drawn to this sort of stock --and few people owned Pfizer just for Trovan, probably. I have heard that some Mutual Fund managers are not allowed to own stocks which trade below $5--and that one cannot buy on margin stocks which trade below $5. I've not tried to confirm that, but it could mean that there are bargains to be found down here. I hope so--but I am willing to admit there are also a lot of junky stocks down here--especially in other sectors of the market other than biotech. I used to follow some penny gold mining stocks, not anymore. If you don't already have the abstracts, I think these are the correct urls to print them out. I do not think there is anything we have not already heard. I agree that Monday could provide a signal--so long as MAGN does not show up on any of the daytrader threads here on SI. In that case upward moves can often be contrary signals--spam and slam. diabetes.org There was an equivalent improvement in wound score, wound infection score, area, and depth for each treatment. Pexiganan is Active Against Resistant Bacteria Isolated from Infected Diabetic Foot Ulcers diabetes.org